Bruker Other Current Assets from 2010 to 2024

BRKR Stock  USD 58.38  0.88  1.53%   
Bruker Other Current Assets yearly trend continues to be relatively stable with very little volatility. Other Current Assets are likely to grow to about 108 M this year. Other Current Assets is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. View All Fundamentals
 
Other Current Assets  
First Reported
2000-03-31
Previous Quarter
113.1 M
Current Value
284.5 M
Quarterly Volatility
91.1 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bruker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bruker's main balance sheet or income statement drivers, such as Interest Expense of 12.1 M, Total Revenue of 3.1 B or Gross Profit of 1.6 B, as well as many indicators such as Price To Sales Ratio of 5.18, Dividend Yield of 0.0026 or PTB Ratio of 14.38. Bruker financial statements analysis is a perfect complement when working with Bruker Valuation or Volatility modules.
  
Check out the analysis of Bruker Correlation against competitors.
To learn how to invest in Bruker Stock, please use our How to Invest in Bruker guide.

Latest Bruker's Other Current Assets Growth Pattern

Below is the plot of the Other Current Assets of Bruker over the last few years. It is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. Bruker's Other Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bruker's overall financial position and show how it may be relating to other accounts over time.
Other Current Assets10 Years Trend
Very volatile
   Other Current Assets   
       Timeline  

Bruker Other Current Assets Regression Statistics

Arithmetic Mean122,211,453
Geometric Mean89,349,168
Coefficient Of Variation59.73
Mean Deviation48,060,558
Median106,600,000
Standard Deviation73,001,677
Sample Variance5329.2T
Range333.7M
R-Value(0.04)
Mean Square Error5728.6T
R-Squared0
Significance0.88
Slope(701,563)
Total Sum of Squares74609.4T

Bruker Other Current Assets History

2024108 M
202385.8 M
202272.3 M
2021176.6 M
2020165.6 M
2019172 M
2018115.1 M

About Bruker Financial Statements

Bruker shareholders use historical fundamental indicators, such as Other Current Assets, to determine how well the company is positioned to perform in the future. Although Bruker investors may analyze each financial statement separately, they are all interrelated. The changes in Bruker's assets and liabilities, for example, are also reflected in the revenues and expenses on on Bruker's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Current Assets85.8 M108 M

Pair Trading with Bruker

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bruker position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bruker will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bruker Stock

  0.86A Agilent TechnologiesPairCorr
  0.88ME 23Andme HoldingPairCorr
  0.64VALN Valneva SE ADRPairCorr

Moving against Bruker Stock

  0.78DRUG Bright Minds BiosciencesPairCorr
  0.61VANI Vivani MedicalPairCorr
  0.58VCYT VeracytePairCorr
  0.55VCEL Vericel Corp OrdPairCorr
  0.5VERA Vera TherapeuticsPairCorr
The ability to find closely correlated positions to Bruker could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bruker when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bruker - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bruker to buy it.
The correlation of Bruker is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bruker moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bruker moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bruker can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Bruker Stock Analysis

When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.